{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:09:17Z","timestamp":1791857357726,"version":"4.3.4"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institute of Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The parathyroid hormone receptor type 1 (PTH1R) is a G protein-coupled receptor that plays key roles in regulating calcium homeostasis and skeletal development via binding the ligands, PTH and PTH-related protein (PTHrP), respectively. Eiken syndrome is a rare disease of delayed bone mineralization caused by homozygous PTH1R mutations. Of the three mutations identified so far, R485X, truncates the PTH1R C-terminal tail, while E35K and Y134S alter residues in the receptor\u2019s amino-terminal extracellular domain. Here, using a variety of cell-based assays, we show that R485X increases the receptor\u2019s basal rate of cAMP signaling and decreases its capacity to recruit \u03b2-arrestin2 upon ligand stimulation. The E35K and Y134S mutations each weaken the binding of PTHrP leading to impaired \u03b2-arrestin2 recruitment and desensitization of cAMP signaling response to PTHrP but not PTH. Our findings support a critical role for interaction with \u03b2-arrestin in the mechanism by which the PTH1R regulates bone formation.<\/jats:p>","DOI":"10.1038\/s42003-023-04966-0","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T14:02:13Z","timestamp":1685714533000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Altered Signaling and Desensitization Responses in PTH1R Mutants Associated with Eiken Syndrome"],"prefix":"10.1038","volume":"6","author":[{"given":"Ignacio","family":"Portales-Castillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9871-8333","authenticated-orcid":false,"given":"Ross W.","family":"Cheloha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan A.","family":"Creemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1217-1435","authenticated-orcid":false,"given":"Jean-Pierre","family":"Vilardaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofya","family":"Savransky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"J\u00fcppner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2163-5772","authenticated-orcid":false,"given":"Thomas J.","family":"Gardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,2]]},"reference":[{"key":"4966_CR1","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/nrendo.2015.139","volume":"11","author":"RW Cheloha","year":"2015","unstructured":"Cheloha, R. W., Gellman, S. H., Vilardaga, J. P. & Gardella, T. J. PTH receptor-1 signalling-mechanistic insights and therapeutic prospects. Nat. Rev. Endocrinol. 11, 712\u2013724 (2015).","journal-title":"Nat. Rev. Endocrinol."},{"key":"4966_CR2","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1210\/endrev\/bnab005","volume":"42","author":"TJ Martin","year":"2021","unstructured":"Martin, T. J., Sims, N. A. & Seeman, E. Physiological and pharmacological roles of PTH and PTHrP in bone using their shared receptor, PTH1R. Endocr. Rev. 42, 383\u2013406 (2021).","journal-title":"Endocr. Rev."},{"key":"4966_CR3","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1210\/me.2007-0274","volume":"22","author":"T Dean","year":"2008","unstructured":"Dean, T., Vilardaga, J. P., Potts, J. T. Jr. & Gardella, T. J. Altered selectivity of parathyroid hormone (PTH) And PTH-related protein (PTHrp) for distinct conformations of the PTH\/PTHrp receptor. Mol. Endocrinol. 22, 156\u2013166 (2008).","journal-title":"Mol. Endocrinol."},{"key":"4966_CR4","doi-asserted-by":"publisher","first-page":"3468","DOI":"10.1016\/j.molcel.2022.07.003","volume":"82","author":"K Kobayashi","year":"2022","unstructured":"Kobayashi, K. et al. Endogenous ligand recognition and structural transition of a human PTH receptor. Mol. Cell 82, 3468\u20133483.e3465 (2022).","journal-title":"Mol. Cell"},{"key":"4966_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34009-x","volume":"13","author":"X Zhai","year":"2022","unstructured":"Zhai, X. et al. Molecular insights into the distinct signaling duration for the peptide-induced PTH1R activation. Nat. Commun. 13, 6276 (2022).","journal-title":"Nat. Commun."},{"key":"4966_CR6","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/BF00572767","volume":"141","author":"M Eiken","year":"1984","unstructured":"Eiken, M., Prag, J., Petersen, K. E. & Kaufmann, H. J. A new familial skeletal dysplasia with severely retarded ossification and abnormal modeling of bones especially of the epiphyses, the hands, and feet. Eur. J. Pediatr. 141, 231\u2013235 (1984).","journal-title":"Eur. J. Pediatr."},{"key":"4966_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/hmg\/ddi001","volume":"14","author":"S Duchatelet","year":"2005","unstructured":"Duchatelet, S., Ostergaard, E., Cortes, D., Lemainque, A. & Julier, C. Recessive mutations in PTH1R cause contrasting skeletal dysplasias in Eiken and Blomstrand syndromes. Hum. Mol. Genet. 14, 1\u20135 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"4966_CR8","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/cge.13413","volume":"94","author":"A Moirangthem","year":"2018","unstructured":"Moirangthem, A. et al. Report of second case and clinical and molecular characterization of Eiken syndrome. Clin. Genet. 94, 457\u2013460 (2018).","journal-title":"Clin. Genet."},{"key":"4966_CR9","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/cge.13601","volume":"96","author":"P Jacob","year":"2019","unstructured":"Jacob, P., Soni, J. P., Mortier, G. & Girisha, K. M. The third family with Eiken syndrome. Clin. Genet. 96, 378\u2013379 (2019).","journal-title":"Clin. Genet."},{"key":"4966_CR10","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/jbmr.5650110505","volume":"11","author":"E Blind","year":"1996","unstructured":"Blind, E., Bambino, T., Huang, Z., Bliziotes, M. & Nissenson, R. A. Phosphorylation of the cytoplasmic tail of the PTH\/PTHrP receptor. J. Bone Miner. Res. 11, 578\u2013586 (1996).","journal-title":"J. Bone Miner. Res."},{"key":"4966_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/mend.16.1.0760","volume":"16","author":"HA Tawfeek","year":"2002","unstructured":"Tawfeek, H. A., Qian, F. & Abou-Samra, A. B. Phosphorylation of the receptor for PTH and PTHrP is required for internalization and regulates receptor signaling. Mol. Endocrinol. 16, 1\u201313 (2002).","journal-title":"Mol. Endocrinol."},{"key":"4966_CR12","first-page":"149","volume":"15","author":"SL Ferrari","year":"2001","unstructured":"Ferrari, S. L. & Bisello, A. Cellular distribution of constitutively active mutant parathyroid hormone (PTH)\/PTH-related protein receptors and regulation of cyclic adenosine 3\u2019,5\u2019-monophosphate signaling by beta-arrestin2. Mol. Endocrinol. 15, 149\u2013163 (2001).","journal-title":"Mol. Endocrinol."},{"key":"4966_CR13","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.1210\/en.2002-220232","volume":"143","author":"M Castro","year":"2002","unstructured":"Castro, M. et al. Dual regulation of the parathyroid hormone (PTH)\/PTH-related peptide receptor signaling by protein kinase C and beta-arrestins. Endocrinology 143, 3854\u20133865 (2002).","journal-title":"Endocrinology"},{"key":"4966_CR14","doi-asserted-by":"publisher","first-page":"4173","DOI":"10.1042\/BCJ20160740","volume":"473","author":"D Zindel","year":"2016","unstructured":"Zindel, D. et al. Identification of key phosphorylation sites in PTH1R that determine arrestin3 binding and fine-tune receptor signaling. Biochem. J. 473, 4173\u20134192 (2016).","journal-title":"Biochem. J."},{"key":"4966_CR15","doi-asserted-by":"publisher","first-page":"5556","DOI":"10.1074\/jbc.RA118.001737","volume":"293","author":"Q Zhang","year":"2018","unstructured":"Zhang, Q. et al. Site-specific polyubiquitination differentially regulates parathyroid hormone receptor-initiated MAPK signaling and cell proliferation. J. Biol. Chem. 293, 5556\u20135571 (2018).","journal-title":"J. Biol. Chem."},{"key":"4966_CR16","doi-asserted-by":"publisher","first-page":"eabc5944","DOI":"10.1126\/scisignal.abc5944","volume":"14","author":"AD White","year":"2021","unstructured":"White, A. D. et al. Spatial bias in cAMP generation determines biological responses to PTH type 1 receptor activation. Sci. Signal. 14, eabc5944 (2021).","journal-title":"Sci. Signal."},{"key":"4966_CR17","doi-asserted-by":"publisher","first-page":"R39","DOI":"10.1530\/JME-14-0093","volume":"53","author":"AS Chagin","year":"2014","unstructured":"Chagin, A. S. & Kronenberg, H. M. Role of G-proteins in the differentiation of epiphyseal chondrocytes. J. Mol. Endocrinol. 53, R39\u2013R45 (2014).","journal-title":"J. Mol. Endocrinol."},{"key":"4966_CR18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00784-013-1014-3","volume":"18","author":"H Roth","year":"2014","unstructured":"Roth, H. et al. Expanding the spectrum of PTH1R mutations in patients with primary failure of tooth eruption. Clin. Oral. Investig. 18, 377\u2013384 (2014).","journal-title":"Clin. Oral. Investig."},{"key":"4966_CR19","doi-asserted-by":"publisher","first-page":"e0167033","DOI":"10.1371\/journal.pone.0167033","volume":"11","author":"H Subramanian","year":"2016","unstructured":"Subramanian, H. et al. PTH1R mutants found in patients with primary failure of tooth eruption disrupt G-protein signaling. PLoS ONE 11, e0167033 (2016).","journal-title":"PLoS ONE"},{"key":"4966_CR20","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1177\/0022034520901731","volume":"99","author":"E Izumida","year":"2020","unstructured":"Izumida, E. et al. Functional analysis of PTH1R variants found in primary failure of eruption. J. Dent. Res. 99, 429\u2013436 (2020).","journal-title":"J. Dent. Res."},{"key":"4966_CR21","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1073\/pnas.1810200115","volume":"116","author":"A Takahashi","year":"2019","unstructured":"Takahashi, A. et al. Autocrine regulation of mesenchymal progenitor cell fates orchestrates tooth eruption. Proc. Natl Acad. Sci. USA 116, 575\u2013580 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4966_CR22","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41574-021-00488-z","volume":"17","author":"CS Kovacs","year":"2021","unstructured":"Kovacs, C. S. et al. The role of biomineralization in disorders of skeletal development and tooth formation. Nat. Rev. Endocrinol. 17, 336\u2013349 (2021).","journal-title":"Nat. Rev. Endocrinol."},{"key":"4966_CR23","doi-asserted-by":"publisher","first-page":"9865","DOI":"10.1074\/jbc.M117.782987","volume":"292","author":"Y Yin","year":"2017","unstructured":"Yin, Y. et al. Rearrangement of a polar core provides a conserved mechanism for constitutive activation of class B G protein-coupled receptors. J. Biol. Chem. 292, 9865\u20139881 (2017).","journal-title":"J. Biol. Chem."},{"key":"4966_CR24","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1210\/jc.2018-00332","volume":"103","author":"H Saito","year":"2018","unstructured":"Saito, H. et al. Progression of mineral ion abnormalities in patients with jansen metaphyseal chondrodysplasia. J. Clin. Endocrinol. Metab. 103, 2660\u20132669 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4966_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33307-8","volume":"13","author":"RS Haider","year":"2022","unstructured":"Haider, R. S. et al. \u03b2-arrestin1 and 2 exhibit distinct phosphorylation-dependent conformations when coupling to the same GPCR in living cells. Nat. Commun. 13, 5638 (2022).","journal-title":"Nat. Commun."},{"key":"4966_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36797-2","volume":"14","author":"Y Aydin","year":"2023","unstructured":"Aydin, Y. et al. Structural details of a Class B GPCR-arrestin complex revealed by genetically encoded crosslinkers in living cells. Nat. Commun. 14, 1151 (2023).","journal-title":"Nat. Commun."},{"key":"4966_CR27","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1210\/endo.135.4.7523099","volume":"135","author":"CW Lee","year":"1994","unstructured":"Lee, C. W. et al. Role of the extracellular regions of the parathyroid-hormone (PTH) PTH-related peptide receptor in hormone-binding. Endocrinology 135, 1488\u20131495 (1994).","journal-title":"Endocrinology"},{"key":"4966_CR28","doi-asserted-by":"publisher","first-page":"5864","DOI":"10.1073\/pnas.1301674110","volume":"110","author":"A Maeda","year":"2013","unstructured":"Maeda, A. et al. Critical role of parathyroid hormone (PTH) receptor-1 phosphorylation in regulating acute responses To PTH. Proc. Natl Acad. Sci. USA 110, 5864\u20135869 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4966_CR29","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/nature00816","volume":"417","author":"M Mahon","year":"2002","unstructured":"Mahon, M., Donowitz, M., Yun, C. & Segre, G. Na(+)\/H(+) exchanger regulatory factor 2 directs parathyroid hormone 1 receptor signalling. Nature 417, 858\u2013861 (2002).","journal-title":"Nature"},{"key":"4966_CR30","doi-asserted-by":"publisher","first-page":"30355","DOI":"10.1074\/jbc.M110.114900","volume":"285","author":"C Klenk","year":"2010","unstructured":"Klenk, C. et al. Formation of a ternary complex among NHERF1, beta-arrestin, and parathyroid hormone receptor. J. Biol. Chem. 285, 30355\u201330362 (2010).","journal-title":"J. Biol. Chem."},{"key":"4966_CR31","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.cell.2016.07.004","volume":"166","author":"AR Thomsen","year":"2016","unstructured":"Thomsen, A. R. et al. GPCR-G protein-beta-arrestin super-complex mediates sustained G protein signaling. Cell 166, 907\u2013919 (2016).","journal-title":"Cell"},{"key":"4966_CR32","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/s41422-019-0256-2","volume":"29","author":"W Yin","year":"2019","unstructured":"Yin, W. et al. A complex structure of arrestin-2 bound to a G protein-coupled receptor. Cell Res. 29, 971\u2013983 (2019).","journal-title":"Cell Res."},{"key":"4966_CR33","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41586-020-1954-0","volume":"579","author":"DP Staus","year":"2020","unstructured":"Staus, D. P. et al. Structure of the M2 muscarinic receptor-\u03b2-arrestin complex in a lipid nanodisc. Nature 579, 297\u2013302 (2020).","journal-title":"Nature"},{"key":"4966_CR34","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1210\/me.2014-1129","volume":"29","author":"PH Carter","year":"2015","unstructured":"Carter, P. H. et al. Actions of the small molecule ligands SW106 and AH-3960 on the type-1 parathyroid hormone receptor. Mol. Endocrinol. 29, 307\u2013321 (2015).","journal-title":"Mol. Endocrinol."},{"key":"4966_CR35","doi-asserted-by":"crossref","unstructured":"Yu, Z. et al. Kinetic and thermodynamic insights into agonist interactions with the parathyroid hormone receptor-1 from a new NanoBRET assay. ACS Chem. Biol. 17, 3148\u20133158 (2022).","DOI":"10.1021\/acschembio.2c00595"},{"key":"4966_CR36","doi-asserted-by":"publisher","first-page":"13224","DOI":"10.1021\/bi026162k","volume":"41","author":"M Shimizu","year":"2002","unstructured":"Shimizu, M. et al. Residue 19 of the parathyroid hormone (PTH) modulates ligand interaction with the juxtamembrane region of the PTH-1 receptor. Biochemistry 41, 13224\u201313233 (2002).","journal-title":"Biochemistry"},{"key":"4966_CR37","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S1534-5807(02)00218-6","volume":"3","author":"J Guo","year":"2002","unstructured":"Guo, J., Chung, U. I., Kondo, H., Bringhurst, F. R. & Kronenberg, H. M. The PTH\/PTHrP receptor can delay chondrocyte hypertrophy in vivo without activating phospholipase C. Dev. Cell 3, 183\u2013194 (2002).","journal-title":"Dev. Cell"},{"key":"4966_CR38","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1126\/science.7701349","volume":"268","author":"E Schipani","year":"1995","unstructured":"Schipani, E., Kruse, K. & Juppner, H. A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 268, 98\u2013100 (1995).","journal-title":"Science"},{"key":"4966_CR39","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.1210\/endo.136.9.7649096","volume":"136","author":"J Guo","year":"1995","unstructured":"Guo, J. et al. Parathyroid hormone (PTH)\/PTH-related peptide receptor density modulates activation of phospholipase C and phosphate transport by PTH in LLC-PK1 cells. Endocrinology 136, 3884\u20133891 (1995).","journal-title":"Endocrinology"},{"key":"4966_CR40","first-page":"e10604","volume":"6","author":"I Portales-Castillo","year":"2022","unstructured":"Portales-Castillo, I., Dean, T., Khatri, A., J\u00fcppner, H. & Gardella, T. J. Functional properties of two distinct PTH1R mutants associated with either skeletal defects or pseudohypoparathyroidism. JBMR 6, e10604 (2022).","journal-title":"JBMR"},{"key":"4966_CR41","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1210\/endo.142.4.8103","volume":"142","author":"PH Carter","year":"2001","unstructured":"Carter, P. H. et al. Selective and nonselective inverse agonists for constitutively active type-1 parathyroid hormone receptors: evidence for altered receptor conformations. Endocrinology 142, 1534\u20131545 (2001).","journal-title":"Endocrinology"},{"key":"4966_CR42","first-page":"e10441","volume":"5","author":"T Sato","year":"2020","unstructured":"Sato, T. et al. Comparable initial engagement of intracellular signaling pathways by parathyroid hormone receptor ligands teriparatide, abaloparatide, and long-acting PTH. JBMR 5, e10441 (2020).","journal-title":"JBMR"},{"key":"4966_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12178","volume":"7","author":"Y Namkung","year":"2016","unstructured":"Namkung, Y. et al. Monitoring G protein-coupled receptor and beta-arrestin trafficking in live cells using enhanced bystander BRET. Nat. Commun. 7, 12178 (2016).","journal-title":"Nat. Commun."},{"key":"4966_CR44","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/j.cell.2022.03.042","volume":"185","author":"WB Asher","year":"2022","unstructured":"Asher, W. B. et al. GPCR-mediated beta-arrestin activation deconvoluted with single-molecule precision. Cell 185, 1661\u20131675 (2022). e1616.","journal-title":"Cell"},{"key":"4966_CR45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cellsig.2017.01.024","volume":"41","author":"S Rajagopal","year":"2018","unstructured":"Rajagopal, S. & Shenoy, S. K. GPCR desensitization: acute and prolonged phases. Cell Signal 41, 9\u201316 (2018).","journal-title":"Cell Signal"},{"key":"4966_CR46","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/nchembio.206","volume":"5","author":"S Ferrandon","year":"2009","unstructured":"Ferrandon, S. et al. Sustained cyclic AMP production by parathyroid hormone receptor endocytosis. Nat. Chem. Biol. 5, 734\u2013742 (2009).","journal-title":"Nat. Chem. Biol."},{"key":"4966_CR47","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1002\/jbmr.3913","volume":"35","author":"H Noda","year":"2020","unstructured":"Noda, H. et al. An inverse agonist ligand of the PTH receptor partially rescues skeletal defects in a mouse model of Jansen\u2019s metaphyseal chondrodysplasia. J. Bone Min. Res 35, 540\u2013549 (2020).","journal-title":"J. Bone Min. Res"},{"key":"4966_CR48","doi-asserted-by":"publisher","first-page":"14486","DOI":"10.1021\/jacs.9b04179","volume":"141","author":"S Liu","year":"2019","unstructured":"Liu, S. et al. Use of backbone modification to enlarge the spatiotemporal diversity of parathyroid hormone receptor-1 signaling via biased agonism. J. Am. Chem. Soc. 141, 14486\u201314490 (2019).","journal-title":"J. Am. Chem. Soc."},{"key":"4966_CR49","doi-asserted-by":"publisher","first-page":"6846","DOI":"10.1073\/pnas.0605125104","volume":"104","author":"PH Carter","year":"2007","unstructured":"Carter, P. H. et al. Discovery of a small molecule antagonist of the parathyroid hormone receptor by using an N-terminal parathyroid hormone peptide probe. Proc. Natl Acad. Sci. USA 104, 6846\u20136851 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4966_CR50","doi-asserted-by":"publisher","first-page":"3502","DOI":"10.1210\/en.2009-1494","volume":"151","author":"J Guo","year":"2010","unstructured":"Guo, J. et al. Phospholipase C signaling via the parathyroid hormone (PTH)\/PTH-related peptide receptor is essential for normal bone responses to PTH. Endocrinology 151, 3502\u20133513 (2010).","journal-title":"Endocrinology"},{"key":"4966_CR51","doi-asserted-by":"publisher","first-page":"10240","DOI":"10.1073\/pnas.93.19.10240","volume":"93","author":"EC Weir","year":"1996","unstructured":"Weir, E. C. et al. Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes skeletal dysplasia and delayed endochondral bone formation. Proc. Natl Acad. Sci. USA 93, 10240\u201310245 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4966_CR52","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1210\/clinem\/dgaa113","volume":"105","author":"JP Bilezikian","year":"2020","unstructured":"Bilezikian, J. P. Hypoparathyroidism. J. Clin. Endocrinol. Metab. 105, 1722\u20131736 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4966_CR53","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1210\/jcem.83.9.5245","volume":"83","author":"P Zhang","year":"1998","unstructured":"Zhang, P., Jobert, A. S., Couvineau, A. & Silve, C. A homozygous inactivating mutation in the parathyroid hormone\/parathyroid hormone-related peptide receptor causing Blomstrand chondrodysplasia. J. Clin. Endocrinol. Metab. 83, 3365\u20133368 (1998).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4966_CR54","doi-asserted-by":"publisher","first-page":"5255","DOI":"10.1210\/endo.139.12.6522","volume":"139","author":"AC Karaplis","year":"1998","unstructured":"Karaplis, A. C. et al. Inactivating mutation in the human parathyroid hormone receptor type 1 gene in Blomstrand chondrodysplasia. Endocrinology 139, 5255\u20135258 (1998).","journal-title":"Endocrinology"},{"key":"4966_CR55","doi-asserted-by":"publisher","first-page":"102332","DOI":"10.1016\/j.jbc.2022.102332","volume":"298","author":"KA Pe\u00f1a","year":"2022","unstructured":"Pe\u00f1a, K. A. et al. Biased GPCR signaling by the native parathyroid hormone\u2013related protein 1 to 141 relative to its N-terminal fragment 1 to 36. J. Biol. Chem. 298, 102332 (2022).","journal-title":"J. Biol. Chem."},{"key":"4966_CR56","doi-asserted-by":"publisher","first-page":"113627","DOI":"10.1016\/j.bcp.2019.113627","volume":"169","author":"PWM Ho","year":"2019","unstructured":"Ho, P. W. M., Chan, A. S., Pavlos, N. J., Sims, N. A. & Martin, T. J. Brief exposure to full length parathyroid hormone-related protein (PTHrP) causes persistent generation of cyclic AMP through an endocytosis-dependent mechanism. Biochem. Pharmacol. 169, 113627 (2019).","journal-title":"Biochem. Pharmacol."},{"key":"4966_CR57","doi-asserted-by":"publisher","first-page":"8121","DOI":"10.1074\/jbc.M110433200","volume":"277","author":"JP Vilardaga","year":"2002","unstructured":"Vilardaga, J. P. et al. Internalization determinants of the parathyroid hormone receptor differentially regulate beta-arrestin\/receptor association. J. Biol. Chem. 277, 8121\u20138129 (2002).","journal-title":"J. Biol. Chem."},{"key":"4966_CR58","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1111\/febs.15773","volume":"288","author":"AH Nguyen","year":"2021","unstructured":"Nguyen, A. H. & Lefkowitz, R. J. Signaling at the endosome: cryo-EM structure of a GPCR-G protein-beta-arrestin megacomplex. FEBS J. 288, 2562\u20132569 (2021).","journal-title":"FEBS J."},{"key":"4966_CR59","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41586-020-1953-1","volume":"579","author":"W Huang","year":"2020","unstructured":"Huang, W. et al. Structure of the neurotensin receptor 1 in complex with \u03b2-arrestin 1. Nature 579, 303\u2013308 (2020).","journal-title":"Nature"},{"key":"4966_CR60","doi-asserted-by":"publisher","first-page":"102406","DOI":"10.1016\/j.sbi.2022.102406","volume":"75","author":"J Maharana","year":"2022","unstructured":"Maharana, J., Banerjee, R., Yadav, M. K., Sarma, P. & Shukla, A. K. Emerging structural insights into GPCR-\u03b2-arrestin interaction and functional outcomes. Curr. Opin. Struct. Biol. 75, 102406 (2022).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"4966_CR61","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.sbi.2017.05.004","volume":"45","author":"XE Zhou","year":"2017","unstructured":"Zhou, X. E., Melcher, K. & Xu, H. E. Understanding the GPCR biased signaling through G protein and arrestin complex structures. Curr. Opin. Struct. Biol. 45, 150\u2013159 (2017).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"4966_CR62","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1124\/mol.109.061804","volume":"77","author":"MD Rochdi","year":"2010","unstructured":"Rochdi, M. D. et al. Functional characterization of vasopressin type 2 receptor substitutions (R137H\/C\/L) leading to nephrogenic diabetes insipidus and nephrogenic syndrome of inappropriate antidiuresis: implications for treatments. Mol. Pharmacol. 77, 836\u2013845 (2010).","journal-title":"Mol. Pharmacol."},{"key":"4966_CR63","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1073\/pnas.1205756110","volume":"110","author":"VL Wehbi","year":"2013","unstructured":"Wehbi, V. L. et al. Noncanonical GPCR signaling arising from a PTH receptor-arrestin-Gbetagamma complex. Proc. Natl Acad. Sci. USA 110, 1530\u20131535 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4966_CR64","doi-asserted-by":"publisher","first-page":"e74101","DOI":"10.7554\/eLife.74101","volume":"11","author":"C Avet","year":"2022","unstructured":"Avet, C. et al. Effector membrane translocation biosensors reveal G protein and betaarrestin coupling profiles of 100 therapeutically relevant GPCRs. Elife 11, e74101 (2022).","journal-title":"Elife"},{"key":"4966_CR65","doi-asserted-by":"publisher","first-page":"928284","DOI":"10.3389\/fendo.2022.928284","volume":"13","author":"T Demaret","year":"2022","unstructured":"Demaret, T. et al. Case report: inactivating PTH\/PTHrP signaling disorder type 1 presenting with PTH resistance. Front. Endocrinol. 13, 928284 (2022).","journal-title":"Front. Endocrinol."},{"key":"4966_CR66","first-page":"1269","volume":"9","author":"C Lee","year":"1995","unstructured":"Lee, C. et al. Homolog-scanning mutagenesis of the parathyroid hormone (PTH) receptor reveals PTH-(1-34) binding determinants in the third extracellular loop. Mol. Endocrinol. 9, 1269\u20131278 (1995).","journal-title":"Mol. Endocrinol."},{"key":"4966_CR67","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671\u2013675 (2012).","journal-title":"Nat. Methods"},{"key":"4966_CR68","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/nchembio.1589","volume":"10","author":"A Gidon","year":"2014","unstructured":"Gidon, A. et al. Endosomal GPCR signaling turned off by negative feedback actions of PKA and v-ATPase. Nat. Chem. Biol. 10, 707\u2013709 (2014).","journal-title":"Nat. Chem. Biol."},{"key":"4966_CR69","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1126\/science.aav7942","volume":"364","author":"L-H Zhao","year":"2019","unstructured":"Zhao, L.-H. et al. Structure and dynamics of the active human parathyroid hormone receptor-1. Science 364, 148\u2013153 (2019).","journal-title":"Science"},{"key":"4966_CR70","doi-asserted-by":"publisher","first-page":"e81563","DOI":"10.7554\/eLife.81563","volume":"11","author":"B Barsi-Rhyne","year":"2022","unstructured":"Barsi-Rhyne, B., Manglik, A. & von Zastrow, M. Discrete GPCR-triggered endocytic modes enable \u03b2-arrestins to flexibly regulate cell signaling. Elife 11, e81563 (2022).","journal-title":"Elife"},{"key":"4966_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15884-8","volume":"11","author":"RW Cheloha","year":"2020","unstructured":"Cheloha, R. W. et al. Improved GPCR ligands from nanobody tethering. Nat. Commun. 11, 2087 (2020).","journal-title":"Nat. Commun."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-04966-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-04966-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-04966-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T15:02:26Z","timestamp":1685718146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-04966-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,2]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4966"],"URL":"https:\/\/doi.org\/10.1038\/s42003-023-04966-0","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,2]]},"assertion":[{"value":"7 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"599"}}